The Community for Technology Leaders
RSS Icon
Subscribe
Issue No.06 - Nov.-Dec. (2012 vol.9)
pp: 1819-1825
H. N. Nounou , Electr. & Comput. Eng. Program, Texas A&M Univ. at Qatar, Doha, Qatar
M. N. Nounou , Chem. Eng. Program, Texas A&M Univ. at Qatar, Doha, Qatar
N. Meskin , Dept. of Electr. Eng., Qatar Univ., Doha, Qatar
A. Datta , Dept. of Electr. & Comput. Eng., Texas A&M Univ., College Station, TX, USA
E. R. Dougherty , Dept. of Electr. & Comput. Eng., Texas A&M Univ., College Station, TX, USA
ABSTRACT
An important objective of modeling biological phenomena is to develop therapeutic intervention strategies to move an undesirable state of a diseased network toward a more desirable one. Such transitions can be achieved by the use of drugs to act on some genes/metabolites that affect the undesirable behavior. Due to the fact that biological phenomena are complex processes with nonlinear dynamics that are impossible to perfectly represent with a mathematical model, the need for model-free nonlinear intervention strategies that are capable of guiding the target variables to their desired values often arises. In many applications, fuzzy systems have been found to be very useful for parameter estimation, model development and control design of nonlinear processes. In this paper, a model-free fuzzy intervention strategy (that does not require a mathematical model of the biological phenomenon) is proposed to guide the target variables of biological systems to their desired values. The proposed fuzzy intervention strategy is applied to three different biological models: a glycolytic-glycogenolytic pathway model, a purine metabolism pathway model, and a generic pathway model. The simulation results for all models demonstrate the effectiveness of the proposed scheme.
INDEX TERMS
Mathematical model, Biological system modeling, Analytical models, Fuzzy models, Computational modeling, Bioinformatics,biological intervention, Fuzzy intervention, model-free intervention, fuzzy systems
CITATION
H. N. Nounou, M. N. Nounou, N. Meskin, A. Datta, E. R. Dougherty, "Fuzzy Intervention in Biological Phenomena", IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol.9, no. 6, pp. 1819-1825, Nov.-Dec. 2012, doi:10.1109/TCBB.2012.113
REFERENCES
[1] I. Shmulevich, E.R. Dougherty, and W. Zhang, “From Boolean to Probabilistic Boolean Networks as Models of Genetic Regulatory Networks,” Proc. IEEE, vol. 90, no. 11, pp. 1778-1792, Nov. 2002.
[2] N. Friedman, M. Linial, I. Nachman, and D. Pe'er, “Using Bayesian Networks to Analyze Expression Data,” J. Computational Biology, vol. 7, pp. 601-620, 2000.
[3] E.O. Voit and J. Almeida, “Decoupling Dynamical Systems for Pathway Identification from Metabolic Profiles,” Bioinformatics, vol. 20, no. 11, pp. 1670-1681, 2004.
[4] I.-C. Chou, H. Martens, and E.O. Voit, “Parameter Estimation in Biochemical Systems Models with Alternating Regression,” Theoretical Biology and Medical Modelling, vol. 3, no. 25, 2006.
[5] H. Wang, L. Qian, and E. Dougherty, “Inference of Genetic Regulatory Networks by Evolutionary Algorithm and H $\infty$ filtering,” Proc. IEEE Statistical Signal Processing Workshop, 2007.
[6] H. Wang, L. Qian, and E. Dougherty, “Steady-State Analysis of Genetic Regulatory Networks Modeled by Nonlinear Ordinary Differential Equations,” Proc. IEEE Symp. Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), 2009.
[7] H. Wang, L. Qian, and E. Dougherty, “Inference of Gene Regulatory Networks Using S-Systems: A Unified Approach,” IET System Biology, vol. 4, no. 2, pp. 145-156, Mar. 2010.
[8] Y. Lee, P.-W. Chen, and E.O. Voit, “Analysis of Operating Principles with S-System Models,” Math. Biosciences, vol. 231, no. 1, pp. 49-60, 2011.
[9] M.A. Savageau, “Biochemical System Analysis, I. Some Mathematical Properties of the Rate Law for the Component Enzymatic Reactions,” J. Theoretical Biology, vol. 25, pp. 365-369, 1969.
[10] E.O. Voit, Canonical Nonlinear Modeling: S-System Approach to Understanding Complexity. Taylor & Francis, 1991.
[11] E. Voit, “A Systems-Theoretical Framework for Health and Disease: Inflammation and Preconditioning from an Abstract Modeling Point of View,” Math. Bioscience, vol. 217, pp. 11-18, 2009.
[12] E.O. Voit, F. Alvarez-Vasquez, and Y.A. Hannun, “Computational Analysis of Sphingolipid Pathways Systems,” Advances in Experimental Medicine and Biology, vol. 688, pp. 264-275, 2010.
[13] R. Gentilini, “Toward Integration of Systems Biology Formalism: the Gene Regulatory Networks Case,” Genome Informatics, vol. 16, pp. 215-224, 2005.
[14] A. Ervadi-Radhakrishnan and E.O. Voit, “Controllabilty of Non-Linear Biochemical Systems,” Math. Biosciences, vol. 196, pp. 99-123, 2005.
[15] N. Meskin, H. Nounou, M. Nounou, A. Datta, and E.R. Dougherty, “Intervention in Biological Phenomena Modeled by S-Systems,” IEEE Trans. Biomedical Eng., vol. 58, no. 5, pp. 1260-1267, May 2011.
[16] K.M. Passino and S. Yurkovich, Fuzzy Control. Addison Wesley, 1998.
[17] H. Zhang and D. Liu, Fuzzy Modeling and Fuzzy Control. Birkhauser, 2006.
[18] Y. Jin and L. Wang, Fuzzy Systems in Bioinformatics and Computational Biology. Springer, 2009.
[19] D. Xu, J. Keller, M. Popescu, and R. Bondugula, Applications of Fuzzy Logic in Bioinformatics. Imperial College Press, 2008.
[20] E.O. Voit, “Fuzzy Logic in Control Systems: Fuzzy Logic Controller-Part i,” IEEE Trans. Systems, Man. and Cybernetics, vol. 20, no. 2, pp. 404-418, Mar./Apr. 1990.
[21] N.V. Torres, “Modelization and Experimental Studies on the Control of the Glycolytic-Glucogenolytic Pathway in Rat Liver,” Molecular and Cellular Biochemistry, vol. 132, no. 2, pp. 117-126, 1994.
[22] E.O. Voit, Computational Analysis of Biochemical System. A Practical Guide for Biochemists and Molecular Biologists. Cambridge Univ. Press, 2000.
190 ms
(Ver 2.0)

Marketing Automation Platform Marketing Automation Tool